One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The selected official and mirror tables agree. Their CRRT guidance is explicitly initial and depends on effluent rather than a CrCl band.
What to reconcile: Confirm modality and L/hour effluent, then reassess residual function and clinical status; do not interpolate a new algorithm.
Open this note and its source referencesThe official label uses CrCl >=120; UCSF prints >120 beside 60-119. The upper effluent band is >=4.1 L/hour in the label versus >4 in UCSF.
What to reconcile: For exactly CrCl 120 the official label is explicit. Preserve the institutional discrepancy and seek clarification for effluent values between printed bands; do not interpolate. This is a wording/boundary comparison, not evidence of different clinical outcomes.
Open this note and its source referencesAt exactly CrCl 120, use the explicit label boundary rather than filling a gap by assumption.
Retain published CRRT precision and seek specialist clarification for values between bands.
Dialysis evidence: CRRT effluent-based initial regimen
For Cockcroft-Gault CrCl >=120 mL/min, the label specifies 2 g every 6 hours over 3 hours; 60-119 uses 2 g every 8 hours. Below 60: 30-59 uses 1.5 g every 8 hours, 15-29 uses 1 g every 8 hours, and <15 (with or without intermittent HD) uses 0.75 g every 12 hours; all infuse over 3 hours. On HD days administer immediately after dialysis.
CRRT initial doses by effluent L/hour are: <=2, 1.5 g every 12 hours; 2.1-3, 2 g every 12 hours; 3.1-4, 1.5 g every 8 hours; >=4.1, 2 g every 8 hours. Reassess residual renal function and clinical status. These printed intervals are not interpolated.
The official CrCl threshold includes exactly 120; the retrieved UCSF heading does not.
RDM59-official-cefiderocol-4cceb3a62f-C1 · Source locator: Sections 2.1 and 2.2, Tables 1 and 2
Selected named sections only; not a complete monograph or independent clinical approval.
Exact DailyMed HTML identity and selected sections read. Raw SPL XML, original-source hashes and complete revision history were not retrieved. Label retrieval does not establish current availability.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=cefiderocol&s1=RDM59-official-cefiderocol-4cceb3a62f&h1=4970ad78951f6082061c6ec2ed2ac192e8dbaf942742a082f60ad5e6390c2bd0